Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey
Part of paid clinical trials in Denver, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT03995082
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Patient Reported Outcome Measure Survey result feedback — OTHERPatients will receive a graph of their results from the PROM survey each time they complete a survey
Study Details
The purpose of this research protocol is to measure Patient Reported Outcome Measures (PROMs) in breast cancer patients. PROM results will be provided to patients and providers and the investigators will evaluate the relationship between patient engagement with PROM results and patient and clinicopathologic variables, utilization of supportive and hospital services, and patient satisfaction with patient-provider communication.
Key Dates
- Start date
- Oct 30, 2019
- Status verified
- Jul 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 925 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Experimental GroupPatients will receive the results from the PROM survey in graphical form each time they complete a survey.
- No Intervention: Normative ControlThese patients will complete the PROM surveys, but will not be presented with the results of the survey.
Primary Outcome Measure
BREAST Q patient satisfaction with breast surgeon domain [ Time Frame: 24 months ]
Central Contacts
- Sarah Tevis3037242731
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cherry Creek Medical Center | Denver | Colorado | 80206 | Sarah Tevis (PRINCIPAL_INVESTIGATOR) |
| University of Colorado Hospital | Denver | Colorado | 80045 | Sarah Tevis Sarah Tevis (PRINCIPAL_INVESTIGATOR) |
| Lone Tree Medical Center | Lone Tree | Colorado | 80124 | - |
Find similar trials in Denver, CO
By condition
By specialty
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After LumpectomyPHASE3 · Recruiting · Rocky Mountain Cancer Centers · Aurora, Colorado
- The Immune System's Response to Young Women's Breast CancerRecruiting · University of Colorado, Denver · Aurora, Colorado
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado